Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.
2.

The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.

Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, Palau F, Nova E, Marcos A, Polanco I, Ribes-Koninckx C, Ortigosa L, Izquierdo L, Sanz Y.

Gut. 2015 Mar;64(3):406-17. doi: 10.1136/gutjnl-2014-306931. Epub 2014 Jun 17.

PMID:
24939571
3.

Spanish national registry of celiac disease: incidence and clinical presentation.

Cilleruelo ML, Roman-Riechmann E, Sanchez-Valverde F, Donat E, Manuel-Ramos J, Martín-Orte E, López MJ, García-Novo D, García S, Pavón P, Martín M, Ortigosa L, Barrio J, Gutierrez C, Espìn B, Castillejo G, Peña-Quintana L, Hualde I, Sebastián M, Calvo C, Fernández S, De Manueles J, Armas H, Urruzuno-Tellerias P, Juste M, Bousoño C, Ribes-Koninckx C.

J Pediatr Gastroenterol Nutr. 2014 Oct;59(4):522-6. doi: 10.1097/MPG.0000000000000446.

PMID:
24886992
4.

Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.

Carvalho CL, Ortigosa LC.

An Bras Dermatol. 2014 Jan-Feb;89(1):154-6. doi: 10.1590/abd1806-4841.20142887.

5.

The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry.

Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E, Navas-López VM; SPIRIT-IBD Working Group of SEGHNP (Sociedad Española de Gastroenterología Hepatología Nutrición Pediátrica).

J Crohns Colitis. 2014 Aug 1;8(8):763-9. doi: 10.1016/j.crohns.2014.01.005. Epub 2014 Jan 24.

PMID:
24462789
6.

Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis.

Ortigosa LC, Silva LC, Duarte AJ, Takahashi MD, Benard G.

Acta Derm Venereol. 2014 Jan;94(1):26-31. doi: 10.2340/00015555-1650.

7.

Influence of breastfeeding versus formula feeding on lymphocyte subsets in infants at risk of coeliac disease: the PROFICEL study.

Pozo-Rubio T, Capilla A, Mujico JR, de Palma G, Marcos A, Sanz Y, Polanco I, García-Novo MD, Castillejo G, Ribes-Koninckx C, Varea V, Palau F, Ortigosa L, Peña-Quintana L, Nova E.

Eur J Nutr. 2013 Mar;52(2):637-46. doi: 10.1007/s00394-012-0367-8. Epub 2012 May 11.

PMID:
22576041
8.

Lucio's phenomenon: another case reported in Brazil.

Monteiro R, Abreu MA, Tiezzi MG, Roncada EV, Oliveira CC, Ortigosa LC.

An Bras Dermatol. 2012 Mar-Apr;87(2):296-300.

9.

Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry.

Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E; SPIRIT-IBD Working Group of Sociedad Española de Gastroenterología, Hepatología y Nutricion Pediátrica.

Inflamm Bowel Dis. 2013 Jan;19(1):73-80. doi: 10.1002/ibd.22980.

PMID:
22535573
10.

Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.

Palma GD, Capilla A, Nova E, Castillejo G, Varea V, Pozo T, Garrote JA, Polanco I, López A, Ribes-Koninckx C, Marcos A, García-Novo MD, Calvo C, Ortigosa L, Peña-Quintana L, Palau F, Sanz Y.

PLoS One. 2012;7(2):e30791. doi: 10.1371/journal.pone.0030791. Epub 2012 Feb 3.

11.

Acne fulminans and isotretinoin: case report.

Pereira MF, Roncada EM, Oliveira CM, Monteiro R, Abreu MA, Ortigosa LC.

An Bras Dermatol. 2011 Sep-Oct;86(5):983-5. English, Portuguese.

12.

Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species.

Sánchez E, De Palma G, Capilla A, Nova E, Pozo T, Castillejo G, Varea V, Marcos A, Garrote JA, Polanco I, López A, Ribes-Koninckx C, García-Novo MD, Calvo C, Ortigosa L, Palau F, Sanz Y.

Appl Environ Microbiol. 2011 Aug;77(15):5316-23. doi: 10.1128/AEM.00365-11. Epub 2011 Jun 3.

13.

Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.

Silva LC, Ortigosa LC, Benard G.

Immunotherapy. 2010 Nov;2(6):817-33. doi: 10.2217/imt.10.67. Review.

PMID:
21091114
14.

Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain.

Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group.

Acta Paediatr. 2010 May;99(5):738-42. doi: 10.1111/j.1651-2227.2010.01684.x. Epub 2010 Jan 21.

PMID:
20096025
15.

Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease.

Fasano A, Araya M, Bhatnagar S, Cameron D, Catassi C, Dirks M, Mearin ML, Ortigosa L, Phillips A; Celiac Disease Working Group, FISPGHAN.

J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):214-9. doi: 10.1097/MPG.0b013e318181afed. No abstract available.

PMID:
18664878
16.

Celiac disease screening by immunochromatographic visual assays: results of a multicenter study.

Baviera LC, Aliaga ED, Ortigosa L, Litwin N, Peña-Quintana L, Méndez V, González MV, López-Manzanares JM, Méndez E, Koninckx CR.

J Pediatr Gastroenterol Nutr. 2007 Nov;45(5):546-50.

PMID:
18030231
17.

Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease.

Ferre-López S, Ribes-Koninckx C, Genzor C, Gamen S, Peña L, Ortigosa L, Méndez E.

Clin Gastroenterol Hepatol. 2004 Jun;2(6):480-4.

PMID:
15181616
18.

A beta-turn rich oats peptide as an antigen in an ELISA method for the screening of coeliac disease in a paediatric population.

Ribes-Koninckx C, Alfonso P, Ortigosa L, Escobar H, Suárez L, Arranz E, Méndez E.

Eur J Clin Invest. 2000 Aug;30(8):702-8.

PMID:
10964162
19.

A novel visual immunoassay for coeliac disease screening.

Garrote JA, Sorell L, Alfonso P, Acevedo B, Ortigosa L, Ribes-Koninckx C, Gavilondo J, Méndez E.

Eur J Clin Invest. 1999 Aug;29(8):697-9.

PMID:
10457154
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk